NCT00874250

Thoracic Endoprosthesis for Treatment of Aneurysm of the Descending Thoracic Aortic

An Evaluation of the GORE Conformable TAG® Thoracic Endoprosthesis for the Primary Treatment of Aneurysm of the Descending Thoracic Aortic

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 51 (actual)
• Sponsor: W.L.Gore & Associates · Industry
• Sex: All
• Age: 21 Years
• Healthy volunteers: Not accepted

Summary

To assess the safety and efficacy of the GORE Conformable TAG® Thoracic Endoprosthesis in the primary treatment of aneurysm of the descending thoracic aorta (DTA) \> Primary Hypothesis: The proportion of subjects free from a major device event through 1 month post-treatment will not be significantly less than 0.95, which represents the proportion observed in previous clinical studies with the GORE TAG® Thoracic Endoprosthesis

Conditions

• Aneurysm

Interventions

Type	Name	Description
DEVICE	GORE CTAG Device	Endovascular aortic stent-graft

Timeline

• Start date: 2009-06-01
• Primary completion: 2011-01-01
• Completion: 2017-01-06
• First posted: 2009-04-02
• Last updated: 2017-08-25
• Results posted: 2011-12-13

Locations

1 site across 1 country: United States